Variant K of butyrylcholinesterase and risk of early-onset type 1 diabetes mellitus in Euro-Brazilians [1]

Diabetes, Obesity and Metabolism

Volumn 8, Issue 6, 2006, Pages 709-711

  Lepienski, Luís M ^a   Souza, Ricardo L R ^a   Chautard Freire Maia, Eleidi A ^a   Alcântara, Vânia M ^a   Réa, Rosangela R ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; GLUCOSE;

ADULT; BRAZIL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYMPTOM;

EID: 33749478508     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00559.x     Document Type: Letter

References (8)

1. Hashim Y, Shepherd D, Wiltshire S et al. Butyrylcholinesterase K variant on chromosome 3q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 2001; 44: 2227-2230.
2. Johansen A, Nielsen E-MD, Andersen G et al. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia 2004; 47: 1437-1441.
3. K, another quantitative variant at cholinesterase locus 1. J Med Genet 1978; 15: 27-29.
4. Mahmoud F, Haines D, Abul H, Omu A. Butyrylcholinesterase activity and pregnancy-associated differences in immunologically relevant peripheral blood leukocyte populations. Am J Reprod Immunol 2003; 50: 77-82.
5. Dietz AA, Rubinstein HM, Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocoline-dithiobis (nitrobenzoic-acid) procedure. Clin Chem 1973; 19: 1309-1313.
6. Miller MP. RxC: A program for analysis of contingency tables via the Metropolis algorithm. Computer software distributed by author, 1997.
7. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV. Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991; 259: 633-638.
8. Thrasher JD, Madison R, Broughton A. Immunologic abnormalities in humans exposed to chlorpyrifos: Preliminary observations. Arch Environ Health 1993; 48: 89-93.